Why Quoin Pharmaceuticals Shares Are Getting Obliterated Wednesday

Quoin Pharmaceuticals Ltd - ADR QNRX shares are trading lower by 42.82% to $0.68 Wednesday morning. The company announced pricing of its $7 million public offering.

What Else?

The offering represents 4,950,000 American Depositary Shares at a purchase price of $1.00 per ADS and pre-funded warrants of 2,050,000 American Depositary Shares at a per pre-funded warrant price of $0.9999.

Quoin Pharmaceuticals says the closing of the offering is expected to occur on or about February 24, subject to the satisfaction of customary closing conditions.

See Also: Why Keysight Technologies Stock Is Trading Lower

The company intends to use the net proceeds from the offering for general corporate purposes.

According to data from Benzinga Pro, QNRX has a 52-week high of $28.11 and a 52-week low of $1.11.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPenny StocksOfferingswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!